Eczema Awareness Monthly – An American Academy of Dermatology Official Licensee
0
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
0
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee
  • Eczema
  • Articles
  • Expert Panel
  • Guidelines
  • Studies
  • Systematic Reviews
  • Patient Resources
Advertisement
EczemaStudies

Effects of ruxolitinib cream on itch and QoL in adult patients with atopic dermatitis

Awareness Monthly
Posted by Awareness Monthly

A study set out to demonstrate the impact of ruxolitinib cream on itch and QoL in patients with atopic dermatitis.

Learn more at the Journal of the American Academy of Dermatology.

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Awareness Monthly
Previous Article Tradipitant response in atopic dermatitis patients with filaggrin loss-of-function variants
Next Article Resource utilization and costs over 3 years following atopic dermatitis claims in the United States

Leave a Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Advertisement

 

Advertisement

 

You Might Also Enjoy

ArticlesEczema

First Topical JAK Inhibitor for Atopic Dermatitis Receives FDA Approval

ArticlesEczema

Pediatric Atopic Dermatitis: Topical Calcineurin Inhibitors

ArticlesEczema

Atopic Dermatitis and COVID-19 Infection Risk

ArticlesEczema

Biologic for Atopic Dermatitis FDA Approved

Load More
Eczema Awareness Monthly - An American Academy of Dermatology Official Licensee

© 2020-2023 Powered by eHealthcare Solutions | Privacy Policy

×